Life science (oncology and neurology preference)
7 Results Found
- Home
- category "Life science (oncology and neurology preference)"
save this search view saved searches new email alert My Favorites
-
MMC Ventures
MMC invests growth equity in dynamic young companies in the UK. We back companies at an early stage and work in partnership with them to grow to substantial scale and profitability. -
Longbow Capital LLP
Longbow is a specialist investor in the unquoted life sciences sector, established in 2004. The Executive Partners have combined experience of investing in over 30 unquoted companies. -
Murray Capital
Murray Capital is a Scottish based private investment company. Headquartered in the heart of Edinburgh's financial district, Charlotte Square. Murray Capital is wholly owned by the Murray Family. -
Albion Ventures LLP
Albion Ventures LLP is one of the largest independent venture capital investors in the UK, managing approximately £230 million across seven Venture Capital Trusts. -
Aurora Funds
The Aurora Funds is a family of venture capital funds committed to providing resources to help early stage healthcare and information technology companies reach their full potential. Aurora’s investment team has the experience, strategic relationships and capital to help companies accelerate their growth and gain a strong competitive advantage in their market space. Since its founding in 1994, Aurora has invested in over 60 portfolio companies, resulting in five IPOs and eight M&A transactions. -
Archangel Informal Investments
Making the Future
Archangel Informal Investment is Scotland's leading Business Angel Syndicate. Originally formed in 1992 and based in Edinburgh, the syndicate now comprises around 100 investor members and is investing c. £10m per year in early stage Scottish companies, including leverage from partners the largest being the Scottish Enterprise Co-Investment Fund. -
Evolve Capital PLC
Evolve was established in order to invest in equities, convertible or non-convertible debt and/or options and warrants in companies which are quoted on, or intending to join, the PLUS-quoted market by way of an IPO.
